Thursday, November 21, 2024 3:20 AM ET
1 day ago
Top Wall Street analysts are upbeat on these stocks for the long haul3 days ago
Activist ValueAct is poised to trim fat, help boost profits at Meta. Here's how3 days ago
Top Wall Street analysts like these dividend-paying stocks10 days ago
Caligan takes a stake in Verona Pharma, sees opportunity to generate more value10 days ago
Goldman Sachs: Why individual investors need to look at private investments11 days ago
Wall Street analysts are confident about the long-term potential of these stocks12 days ago
Activist Jana is back in the kitchen at Lamb Weston – What could happen next17 days ago
Insana: Musk, Paulson seek sharp U.S. budget cuts. This isn't likely to work18 days ago
Vista's Robert Smith: How to prevent AI from further widening racial wealth gap21 days ago
Top Wall Street analysts are upbeat on these dividend stocks24 days ago
How activist Starboard may help boost value in Kenvue's skin and beauty business25 days ago
Insana: The market is on a hot streak, and these factors are driving it25 days ago
Top Wall Street analysts like these stocks for their growth prospects1 month ago
D.E. Shaw, Mantle Ridge zero in on key fixes to build value at Air Products1 month ago
Top Wall Street analysts prefer these dividend stocks for steady income1 month ago
Insana: September consumer inflation report was a blip in a wider cooling trend1 month ago
Top Wall Street analysts favor these stocks for attractive long-term potential1 month ago
How activist Irenic can amicably build shareholder value at Reservoir Media1 month ago
Top Wall Street analysts prefer these dividend stocks to strengthen portfolios1 month ago
How ValueAct can help elevate Sanwa from a good company to a great one1 month ago
Insana: China's rally won't last because its economic problems run too deep1 month ago
Op-ed: The UK's budget problems date back to the 2008 financial crisis1 month ago
Top Wall Street analysts find these stocks promising for the long haul1 month ago
Ron Insana: Fed chair unnecessarily complicated the outlook for interest rates1 month ago
Op-ed: Sale of Bausch + Lomb may lead to windfall for Bausch Health investors2 months ago
Top Wall Street analysts pick these dividend stocks for attractive returns2 months ago
Voss Capital wants to maximize value at International Money Express2 months ago
Ron Insana: Even as inflation cools, risks to the soft landing are rising2 months ago
Top Wall Street analysts are bullish on the potential of these 3 stocks2 months ago
Activist Ancora joins investors' calls for a strategic review at Forward Air2 months ago
Ron Insana: Commodity, financial markets are sending warning message to the Fed2 months ago
Top Wall Street analysts are bullish on these 3 dividend-paying stocks2 months ago
Ron Insana says math adds up to Fed needing to cut interest rates aggressively2 months ago
Engaged Capital might have the recipe to build value at Portillo's2 months ago